INDV vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW
Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.
Indivior vs. Its Competitors
180 Life Sciences (NASDAQ:ATNFW) and Indivior (NASDAQ:INDV) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.
In the previous week, Indivior had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for Indivior and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Indivior's score of 0.47 indicating that 180 Life Sciences is being referred to more favorably in the media.
Indivior has a consensus price target of $17.00, suggesting a potential upside of 9.89%. Given Indivior's stronger consensus rating and higher possible upside, analysts plainly believe Indivior is more favorable than 180 Life Sciences.
Indivior has higher revenue and earnings than 180 Life Sciences.
60.3% of Indivior shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
180 Life Sciences has a net margin of 0.00% compared to Indivior's net margin of -4.02%. 180 Life Sciences' return on equity of 0.00% beat Indivior's return on equity.
Summary
Indivior beats 180 Life Sciences on 8 of the 11 factors compared between the two stocks.
Get Indivior News Delivered to You Automatically
Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INDV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Indivior Competitors List
Related Companies and Tools
This page (NASDAQ:INDV) was last updated on 7/13/2025 by MarketBeat.com Staff
Free INDV Stock Alerts